MENU
+Compare
BOIRF
Stock ticker: OTC
AS OF
Nov 13 closing price
Price
$30.00
Change
-$1.86 (-5.84%)
Capitalization
618.42M

BOIRF Boiron Forecast, Technical & Fundamental Analysis

Boiron SA is a drug manufacturer that focuses on homeopathic products... Show more

BOIRF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BOIRF with price predictions
Dec 24, 2025

BOIRF sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for BOIRF moved above the 200-day moving average on December 05, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 28, 2025. You may want to consider a long position or call options on BOIRF as a result. In of 17 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Bearish Trend Analysis

The Aroon Indicator for BOIRF entered a downward trend on December 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.196) is normal, around the industry mean (24.266). P/E Ratio (22.916) is within average values for comparable stocks, (74.353). BOIRF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.954). Dividend Yield (0.046) settles around the average of (0.030) among similar stocks. P/S Ratio (0.875) is also within normal values, averaging (64.216).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BOIRF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BOIRF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
BOIRF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

BOIRF paid dividends on June 04, 2021

Boiron BOIRF Stock Dividends
А dividend of $0.95 per share was paid with a record date of June 04, 2021, and an ex-dividend date of June 02, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
2, Avenue de l’Ouest Lyonnais No. 039
Phone
+33 478456100
Employees
2801
Web
http://www.boiron.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCIGX13.970.05
+0.36%
VALIC Company I Dividend Value
GCASX46.050.09
+0.20%
Gabelli Small Cap Growth A
DQEIX12.720.02
+0.16%
BNY Mellon Global Equity Income - I
FSYRX11.58N/A
N/A
Fidelity Sustainable International Eq
HFQCX7.12N/A
N/A
Janus Henderson Global Equity Income C

BOIRF and Stocks

Correlation & Price change

A.I.dvisor tells us that BOIRF and ELAN have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOIRF and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOIRF
1D Price
Change %
BOIRF100%
N/A
ELAN - BOIRF
21%
Poorly correlated
+0.72%
BUDZ - BOIRF
7%
Poorly correlated
-2.45%
BSPK - BOIRF
4%
Poorly correlated
N/A
APNHY - BOIRF
3%
Poorly correlated
+2.00%
BIOVF - BOIRF
1%
Poorly correlated
N/A
More

Groups containing BOIRF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOIRF
1D Price
Change %
BOIRF100%
N/A
Pharmaceuticals: Generic
industry (212 stocks)
12%
Poorly correlated
+0.28%